Legend Biotech (LEGN) Receivables - Net (2019 - 2025)
Historic Receivables - Net for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $1.2 million.
- Legend Biotech's Receivables - Net rose 7531.91% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 7531.91%. This contributed to the annual value of $6.3 million for FY2024, which is 9371.56% down from last year.
- According to the latest figures from Q3 2025, Legend Biotech's Receivables - Net is $1.2 million, which was up 7531.91% from $27.6 million recorded in Q2 2025.
- Legend Biotech's 5-year Receivables - Net high stood at $100.0 million for Q4 2023, and its period low was $15000.0 during Q2 2021.
- Over the past 5 years, Legend Biotech's median Receivables - Net value was $2.4 million (recorded in 2021), while the average stood at $16.9 million.
- Data for Legend Biotech's Receivables - Net shows a peak YoY increase of 11105666.67% (in 2023) and a maximum YoY decrease of 9988.9% (in 2023) over the last 5 years.
- Legend Biotech's Receivables - Net (Quarter) stood at $50.4 million in 2021, then tumbled by 99.82% to $90000.0 in 2022, then soared by 111056.67% to $100.0 million in 2023, then tumbled by 93.72% to $6.3 million in 2024, then plummeted by 80.34% to $1.2 million in 2025.
- Its Receivables - Net was $1.2 million in Q3 2025, compared to $27.6 million in Q2 2025 and $369000.0 in Q1 2025.